Use of Sotatercept to Facilitate Transition From Intravenous to Oral Prostacyclin Therapy
ABSTRACT Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance (PVR) leading to right ventricular failure and high mortality. Parenteral prostacyclin therapy remains the cornerstone for high‐risk patients but is limited by complicatio...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2025-12-01
|
| Serija: | The Clinical Respiratory Journal |
| Online pristup: | https://doi.org/10.1111/crj.70149 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|